Far East Financials: Two Large Chinese Device Firms Report Mixed Growth
This article was originally published in The Gray Sheet
Executive Summary
China Medical's molecular diagnostic system sales were up 10% in the first quarter to $15.9 million, driven by progress with its fluorescent in situ hybridization probe business, the Beijing company reported Aug. 16